Novavax Aktie
7,39
EUR
+0,04
EUR
+0,53
%
8,75
USD
+0,06
USD
+0,69
%
Novavax jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 7 | 1 | 1 | 137,81 GBP | - |
| Bayer | 5 | 5 | 0 | 37,83 EUR | -17,79% |
| BioNTech (ADRs) | 4 | 2 | 0 | 136,50 USD | +25,31% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 2 | 5 | 3 | 45,30 EUR | +12,77% |
| Fresenius SE & Co. KGaA (St.) | 7 | 2 | 0 | 53,45 EUR | +7,26% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 112,50 CHF | -7,02% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 1 | 5 | 0 | 28,33 USD | +2,61% |
| Roche AG (Genussschein) | 4 | 4 | 1 | 347,88 CHF | -0,92% |
| Sanofi S.A. | 5 | 4 | 0 | 97,62 EUR | +19,93% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |